Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration. [NA]

View source ↗

Summary

A preliminary clinical trial is investigating the effect of GLP-1 on intestinal barrier function in patients with short bowel syndrome and intestinal failure; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Short Bowel Syndrome (SBS), Intestinal Failure | NA | Status: RECRUITING